{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:17:56Z","timestamp":1785161876536,"version":"3.55.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore the association of plasma brain-derived neurotrophic factor (BDNF) levels with Alzheimer\u2019s disease and its influencing factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A total of 1,615 participants were included in the present study. Among all subjects, 660 were cognitive normal controls (CNCs), 571 were mild cognitive impairment (MCI) patients, and 384 were dementia with Alzheimer\u2019s type (DAT) patients. BDNF in blood samples collected from these subjects was analyzed via the Luminex assay. Additionally, DNA extraction and APOE4 genotyping were performed on leukocytes using a blood genotyping DNA extraction kit. All data were processed with SPSS 20.0 software. Analysis of variance (ANOVA) or analysis of covariance (ANCOVA) was used to compare differences among groups on plasma BDNF. Pearson and Spearman correlation analysis examined the correlation between BDNF and cognitive impairment, and linear regression analysis examined the comprehensive effects of diagnosis, gender, age, education, and sample source on BDNF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>BDNF levels in DAT patients were higher than those in CNC and MCI patients (<jats:italic>P<\/jats:italic> &amp;lt; 0.01). BDNF levels were significantly correlated with CDR, MMSE, and clinical diagnosis (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). Age, education, occupation, and sample source had significant effects on BDNF differences among the CNC, MCI, and DAT groups (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). BDNF first decreased and then increased with cognitive impairment in the ApoE4-negative group (<jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma BDNF levels decreased in the MCI stage and increased in the dementia stage and were affected by age, education, occupation, and sample source. Unless the effects of sample heterogeneity and methodological differences can be excluded, plasma BDNF is difficult to become a biomarker for the early screening and diagnosis of AD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2022.987244","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T13:13:51Z","timestamp":1667913231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of plasma brain-derived neurotrophic factor with Alzheimer\u2019s disease and its influencing factors in Chinese elderly population"],"prefix":"10.3389","volume":"14","author":[{"given":"Fuqiang","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaohuo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"B1","first-page":"367","article-title":"The clinical dementia rating (simplified Chinese).","volume":"37","year":"2018","journal-title":"Chin. J. Geriat."},{"key":"B2","year":"2017","journal-title":"Alzheimer\u2019s disease facts and figures."},{"key":"B3","doi-asserted-by":"publisher","year":"2013","journal-title":"Diagnostic and statical manual of mental disorder, DSM-V.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/156720510790274473","article-title":"Alzheimer\u2019s disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF Serum levels.","volume":"7","author":"Angelucci","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1007\/s12035-017-0866-y","article-title":"Peripheral blood brain-derived neurotrophic factor as a biomarker of Alzheimer\u2019s disease: Are there methodological biases?","volume":"55","author":"Balietti","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications.","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000450601","article-title":"Brain-derived neurotrophic factor serum levels and hippocampal volume in mild cognitive impairment and dementia due to Alzheimer disease.","volume":"6","author":"Borba","year":"2016","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"B8","first-page":"806","article-title":"Discussion on related matter of Alzheimers disease.","volume":"37","author":"Cheng","year":"2020","journal-title":"J. Clin. Res."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00414","article-title":"Blood-Derived plasma protein biomarkers for Alzheimer\u2019s disease in Han Chinese.","volume":"10","author":"Cheng","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B10","first-page":"54","article-title":"Hachinski ischemic scale (HIS).","author":"Fan","year":"1990","journal-title":"Shanghai Arch. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jpsychires.2014.01.019","article-title":"Increased plasma levels of BDNF and inflammatory markers in Alzheimer\u2019s disease.","volume":"53","author":"Faria","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"B12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-150172","article-title":"Decreased neurotrophic support is associated with cognitive decline in non-demented subjects.","volume":"46","author":"Forlenza","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost."},{"key":"B14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ajmg.b.30986","article-title":"Sexually dimorphic effect of the val66met polymorphism of BDNF on susceptibility to Alzheimer\u2019s disease: New data and meta-analysis.","author":"Fukumoto","year":"2010","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12031-021-01824-8","article-title":"Investigation of the molecular role of brain-derived neurotrophic factor in Alzheimer\u2019s disease.","volume":"72","author":"Girotra","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4537274","article-title":"Changes in circulating BDNF in relation to sex, diet, and exercise: A 12-week randomized controlled study in overweight and obese participants.","volume":"2019","author":"Glud","year":"2019","journal-title":"J. Obes."},{"key":"B17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.","volume":"31","author":"Hixson","year":"1990","journal-title":"J. Lipid Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1007\/s12035-016-0192-9","article-title":"Peripheral brain-derived neurotrophic factor levels in Alzheimer\u2019s disease and mild cognitive impairment: A comprehensive systematic review and meta-analysis.","volume":"54","author":"Kim","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S1461145710000738","article-title":"Blood BDNF concentrations reflect brain-tissue BDNF levels across species.","volume":"14","author":"Klein","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease.","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-005-0397-y","article-title":"Stage-dependent BDNF serum concentrations in Alzheimer\u2019s disease.","volume":"113","author":"Laske","year":"2006","journal-title":"J. Neural Transm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: Self-maintaining and instrumental activities of daily living.","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.9758\/cpn.2015.13.3.283","article-title":"Brain-derived Neurotrophic factor is associated with cognitive impairment in elderly korean individuals.","volume":"13","author":"Lee","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"B24","first-page":"66","article-title":"Preliminary application of MMSE in the aged of urban population in Beijing.","volume":"2","author":"Li","year":"1988","journal-title":"Chin. Ment. Health J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s12035-014-8804-8","article-title":"Associations between ApoE\u03b54 carrier status and serum BDNF Levels\u2014New insights into the molecular mechanism of ApoE\u03b54 actions in Alzheimer\u2019s disease.","volume":"51","author":"Liu","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","article-title":"The impact of age, weight and gender on BDNF levels in human platelets and plasma.","volume":"26","author":"Lommatzsch","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s40520-021-02069-6","article-title":"The impact of physical activity on blood inflammatory cytokines and neuroprotective factors in individuals with mild cognitive impairment: A systematic review and meta-analysis of randomized-controlled trials.","volume":"34","author":"Ma","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/rej.2020.2307","article-title":"Is blood brain-derived neurotrophic factor a useful biomarker to monitor mild cognitive impairment patients?","volume":"23","author":"Marta","year":"2020","journal-title":"Rejuvenation Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.653267","article-title":"Serum BDNF as a potential biomarker of Alzheimer\u2019s disease: Verification through assessment of serum, cerebrospinal fluid, and medial temporal lobe atrophy.","volume":"12","author":"Mori","year":"2021","journal-title":"Front. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2174\/156720501108140910122849","article-title":"Physical exercise in MCI elderly promotes reduction of pro-inflammatory cytokines and improvements on cognition and BDNF peripheral levels.","volume":"11","author":"Nascimento","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"22666","DOI":"10.18632\/aging.203598","article-title":"Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: A case-control study.","volume":"13","author":"Ng","year":"2021","journal-title":"Aging"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020257","article-title":"Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with Alzheimer\u2019s disease (AD): A systematic review and meta-analysis.","volume":"20","author":"Ng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000321980","article-title":"Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer\u2019s disease cases.","volume":"31","author":"O\u2019Bryant","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier.","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment\u2013Clinical characterization and outcome.","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/14728222.2019.1572747","article-title":"Neuronal and behavioral plasticity: The role of serotonin and BDNF systems tandem.","volume":"23","author":"Popova","year":"2019","journal-title":"Exp. Opin. Ther. Tar."},{"key":"B38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/mp.2016.62","article-title":"Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer\u2019s disease: A meta-analysis study (N=7277).","volume":"22","author":"Qin","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101066","article-title":"Proteomics as a reliable approach for discovery of blood-based Alzheimer\u2019s disease biomarkers: A systematic review and meta-analysis.","volume":"60","author":"Rehiman","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pjnns.2016.10.001","article-title":"Cognitive impairment and BDNF serum levels.","volume":"51","author":"Siuda","year":"2017","journal-title":"Neurol. Neurochir. Pol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/00207454.2012.762515","article-title":"Val66Met polymorphism and BDNF levels in Alzheimer\u2019s disease patients in North Indian population.","volume":"123","author":"Sonali","year":"2013","journal-title":"Int. J. Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s12035-014-8958-4","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease: Risk, mechanisms, and therapy.","volume":"52","author":"Song","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B43","first-page":"825","article-title":"Correlations between the serum levels of Irisin, FNDC5, BDNF and cognitive function in patients with Alzheimer\u2019s disease.","volume":"20","author":"Tang","year":"2020","journal-title":"J. Trop. Med."},{"key":"B44","first-page":"89","article-title":"Validity and reliability of the Chinese version of the Alzheimer\u2019s disease assessment scale.","volume":"8","author":"Wang","year":"2000","journal-title":"Inst. Ment. Health"},{"key":"B45","first-page":"176","article-title":"Change and its significance of serum levels of brain-derived neurotrophic factor in patients with Alzheimer disease.","volume":"3","author":"Wang","year":"2015","journal-title":"J. Brain Nerv. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/156720512802455395","article-title":"BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease.","volume":"9","author":"Woolley","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"B47","first-page":"1211","article-title":"Brief Elderly cognitive screening inventory: Development, reliability and validity.","volume":"36","author":"Wu","year":"2016","journal-title":"Chin. J. Gerontol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/00207454.2019.1667794","article-title":"Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer\u2019s disease and mild cognitive impairment: Results of a meta-analysis.","volume":"130","author":"Xie","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: An update.","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"B50","first-page":"151","article-title":"Changes in serum brain-derived neurotrophic factor levels in patients with Alzheimer\u2019s disease.","volume":"38","author":"Zhang","year":"2019","journal-title":"Chin. J. Geriatr."},{"key":"B51","first-page":"214","article-title":"Reliability and validity of Hamilton depression scale assessed in 329 Chinese depression patients.","volume":"5","author":"Zhao","year":"1992","journal-title":"Chin. Ment. Health J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/01616412.2020.1716467","article-title":"The prevalence of Alzheimer\u2019s disease in the Chinese Han population: A meta-analysis.","volume":"42","author":"Zhao","year":"2020","journal-title":"Neurol. Res."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.987244\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T13:14:06Z","timestamp":1667913246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.987244\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":52,"alternative-id":["10.3389\/fnagi.2022.987244"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.987244","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"article-number":"987244"}}